Pfizer Says Monthly GLP-1 Candidate Could Rival Tirzepatide on Weight Loss

기사 요약

Pfizer stock rises after beating Q2 estimates and raising its 2026 revenue guidance to up to $62.5B. Get the key earnings takeaways.